SRK-256

N/A

Report date: 2024/02/01 17:47:29

Base Information

Drug NameSRK-256
Drug Alias NameSRK-256
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionHemochromatosis type 2 protein inhibitors
TargetsHemochromatosis type 2 protein
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScholar Rock Inc
China Registration ClassN/A

Develop Information

Active CompaniesScholar Rock Inc
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A